Visiting faculty.....SIES college, Chemistry dept, Sion,Mumbai, India. 04 march 2017.....Service to education is service to God, ThanKs to prin Dr Uma Shankar, Vice principal George Abraham
Monday, 6 March 2017
Visiting faculty.....SIES college, Chemistry dept, Sion,Mumbai, India
Visiting faculty.....SIES college, Chemistry dept, Sion,Mumbai, India. 04 march 2017.....Service to education is service to God, ThanKs to prin Dr Uma Shankar, Vice principal George Abraham
Saturday, 4 February 2017
Kate Ashton
Kate Ashton
Senior Scientist at Amgen, Inc
Dr. Kate Ashton received a Masters in Chemistry with Industrial Experience from the University of Edinburgh. She conducted her PhD thesis research on the synthesis and structure elucidation of Reidispongiolide A with Prof. Ian Paterson at the University of Cambridge, and her postdoctoral work on SOMO catalysis with Prof. David W. C. MacMillan at both Caltech and Princeton.
She has been at Amgen for 6 years and has worked on indications for cancer, Alzheimer’s and diabetes.Dr Fecke works in the area of industrial early drug discovery since 1996. He is currently Group Leader in the Primary Pharmacology department at UCB Pharma (UK) and is involved in the identification and characterization of NCE and NBE drugs in molecular interaction assays for both immunological and CNS diseases.
Prior to joining UCB, he worked for Novartis and Siena Biotech in the areas of transplant rejection, neurodegeneration and oncology. He obtained his PhD at the Heinrich-Heine-University Dusseldorf in Germany in 1994.
AMG-3969
M.Wt: 522.46
Cas : 1361224-53-4 , MF: C21H20F6N4O3S
Cas : 1361224-53-4 , MF: C21H20F6N4O3S
WO 2012027261 PRODUCT PATENT
2-[4-[(2S)-4-[(6-Amino-3-pyridinyl)sulfonyl]-2-(1-propyn-1-yl)-1-piperazinyl]phenyl]-1,1,1,3,3,3-hexafluoro-2-propanol)
MAKING CONNECTIONS Aleksandra Baranczak (right), a fourth-year grad student in Gary A. Sulikowski’s lab at Vanderbilt University, discusses her efforts to synthesize the core of the diazo-containing natural product lomaiviticin A with Kate Ashton, a medicinal chemist at Amgen
Experience
Senior Scientist
Amgen, Inc.
Postdoctoral Fellow
Princeton University
Postdoctoral Fellow
California Institute of Technology
Research Associate
Merck, UK
Education
University of Cambridge
Doctor of Philosophy (PhD), Organic Chemistry
Edinburgh University
Masters with Industrial Experience, Organic Chemistry
///////////
Tuesday, 3 January 2017
Dr. Kurt Stoeckli, President & Chief Scientific Officer, Glenmark Pharmaceuticals ltd
Dr. Kurt Stoeckli
President & Chief Scientific Officer
Glenmark Pharmaceuticals ltd
Neuchatel, Switzerland
Links
Having spent more than two decades in the pharmaceutical arena, Dr. Stoeckli has extensive industry experience and joins us from Sanofi where he was Group Vice President for Global Bio Pharmaceuticals Division. He was on their R&D Board, and served as CSO for R&D, France. In his tenure of more than fifteen years with Sanofi he has held progressive leadership positions of – Vice President, Global Head of Therapeutic Unit -Immuno-Inflammation, Vice President - Biological Sciences & Scientific Site Director, Vice President of Biological Sciences, Member of the Sanofi Aventis Discovery Board, Global Head of Discovery Technologies, and lastly Vice President, Global Lead Discovery, Aventis Pharma. Prior to joining Sanofi, Dr. Stoeckli worked for seven years in drug discovery at Novartis/Sandoz in Basel, Switzerland.
Dr. Stoeckli is Postdoctoral Fellow & Assistant Professor from Department of Biochemistry & Biophysics, University of California Medical Center and Ph.D., Cell Biology & Neurosciences from Max-Planck-Institute for Neurobiology.
Experience
President & Chief Scientific Officer
Glenmark Pharmaceuticals ltd
Neuchatel, Switzerland
oct 1 2016.............
Vice President Global Biotherapeutics
SANOFI
Global responsibility within R&D for biologics from discovery up until phase 3 support across therapeutic areas
Deputy to President of Global R&D (ad interim) for Research & Early Development
Sanofi
Global R&D Management
VP R&D Global Head Immuno-Inflammation Unit
sanofi-aventis
Therapeutic area head (Research & Early Development) in the area of immune-mediated and chronic inflammatory diseases
Vice President Biological Sciences & Scientific Director Vitry-Alfortville-Evry Site
Sanofi
Global head of research biologics
Member of R&D board
Scientific Director of Vitry-Alfortville-Evry Site
Member of R&D board
Scientific Director of Vitry-Alfortville-Evry Site
VP Biological Sciences, Discovery Research
sanofi-aventis
Responsibility for newly created research biologics with teams in Frankfurt, Paris, Toulouse, Bridgewater, Cambridge)
Education
Sunday, 25 December 2016
Reflections on Chirality in the Pharmaceutical Industry: Past, Present and Future Dr. Christopher J. Welch, Distinguished Scientist Process Research & Development Merck Research Laboratories, USA
New Technologies, Postdoc Program, Science Lead, Analytical Chemistry at Merck
A PRESENTATION
Christopher J. Welch
Science Lead for Analytical Chemistry
Merck Research Laboratories
Christopher J. Welch is Science Lead for Analytical Chemistry within the Process and Analytical Chemistry area at Merck Research Laboratories in Rahway, NJ. Chris leads the New Technologies Review and Licensing Committee (NT-RLC), the organization that oversees identification, acquisition and evaluation of new technologies of potential value to Merck Research Laboratories. Chris also leads the MRL Postdoctoral Research Fellows Program. He received his BS degrees in Chemistry and Biochemistry from the University of Illinois at Urbana-Champaign in 1982 and a Ph.D. degree in Organic Chemistry (also U of I) in 1992. Dr. Welch has worked in a variety of fields within the chemical industry, including discovery synthesis of agrochemicals (Velsicol-Sandoz), development of reagents for improved immunodiagnostic assays (Abbott Laboratories), and development and commercialization of chromatographic stationary phases, reagents and enantioselective catalysts within a small chemical business environment (Regis Technologies). Since joining Merck in 1999, he has focused on developing and applying improved methods and equipment for purification, synthesis and analysis of pharmaceuticals and intermediates. Dr. Welch has authored more than 230 scientific publications and patents. He is co-founder of the journal, Enantiomer, a current or past member of the editorial advisory boards for the journals, Chirality, Organic & Biomolecular Chemistry, Journal of the Korean Chemical Society, Chemistry World, Chemical & Engineering News and ACS Central Science. Chris is past chair of the ACS Division of Organic Chemistry (ORGN), a member of the Executive Committee for the International Symposia on Chirality, a member of the ACS steering committee for Pacifichem and a member of the PittCon Program Resource Team. Honors and awards include the NJCG Award for Excellence in Chromatography (2004), the PACS Activated Carbon Hall of Fame award (2007), MRL Presidents Award for Environmental Achievement (2009), Microsoft Life Science Innovation Award (2010), Fellow of the American Chemical Society (2010), Fellow of the American Association for the Advancement of Science, AAAS (2013), the Chirality Medal (2015) and the University of Nebraska Industrial Advisory Board Award (2016).
Merck Research Laboratories
Experience
Distinguished Scientist, Process & Analytical Chemistry
Merck & Co., Inc.
Current responsibilities:
Scientific Lead, Analytical Chemistry
co-chair, New Technologies Review & Licensing Committee (NT-RLC)
co-chair, Merck Research Laboratories Postdoctoral Research Fellows Committee
Previous Positions at Merck:
Science Lead, Global Analytical Chemistry 8/10 – 8/12
Distinguished Senior Investigator, Process Research 7/07 – 8/10
Associate Director. Process Research 1/06 – 6/07
Senior Research Fellow, Process Research 6/03 – 12/05
Research Fellow, Process Research 5/99 – 6/03
Director of Research
Regis Technologies
- New product development and commercialization (chromatography columns, reagents, enantioselective catalysts)
- Scientific evaluation of custom organic synthesis business
- Set up contract synthesis/preparative chromatographic separation business - first of kind
Honors & Awards
Fellow
American Association for the Advancement of Science (AAAS)
Fellow
American Chemical Society (ACS)
Chirality Medal 2015
Presidential Green Chemistry Award
US Environmental Protection Agency
– for precompetitive collaboration between Merck, Pfizer, Eli Lilly and University of Wisconsin on Aerobic Oxidation Methods for Pharmaceutical Synthesis - co-awardees: Shannon Stahl and Thatcher Root (U. Wisconsin), Joel Hawkins (Pfizer) and Joe Martinelli (Lilly)
Industrial Advisory Board (IAB) Award
University of Nebraska Department of Chemistry
Inaugural IAB award from U. Nebraska recognizing excellence in scientific research in an industry setting
Organizations
Publications
2014 publications, part 1
Use of a Miniature Mass Spectrometer to Support Pharmaceutical Process Research Investigations, Org. Proc. R&D 18, 103-108, 2014.
Chromatographic Separation and Assignment of Absolute Configuration of Hydroxywarfarin Isomers, Chirality 26, 95-101, 2014.
Chromatographic Resolution of Closely Related Species in Pharmaceutical Chemistry: Dehalogenation Impurities and Mixtures of Halogen...more
2014 publications - part 2
Precompetitive Collaboration on Enabling Technologies for the Pharmaceutical Industry, Org. Proc. R&D 18, 481–487, 2014.
Imine-based Chiroptical Sensing Approach for Analysis of Chiral Amines: From Method Design to Synthetic Application, Chem. Sci. 5, 2855-2861, 2014.
Advances in Achiral Stationary Phases for SFC, Amer. Pharm. Rev., April 2014, 36-41.
Liquid Chromatography Methods for...more
2013 Publications
Evaluation of core–shell particle columns for ion-pair reversed-phase liquid chromatography analysis of oligonucleotides, J. Pharm. Biomed. Anal. 72, 25–32, 2013.
Pharmaceutical Industry Practices on Genotoxic Impurities, in Pharmaceutical Industry Practices on Genotoxic Impurities, ed Heewoon Lee, Taylor & Francis, 2013.
Rapid Analysis of Residual Palladium in Pharmaceutical...more
2012 Publications
2012
A Simple Parallel Gas Chromatography Column Screening System, Wes Schafer, Simon E. Hamilton, Zainab Pirzada and Christopher J. Welch, Chirality, 24,1–4, 2012.
Rapid catalyst identification for the synthesis of the pyrimidinone core of HIV integrase inhibitors, A. Bellomo, N. Celebi-Olcum, X. Bu, N. Rivera, R.T. Ruck, C.J. Welch, K.N. Houk, S.D. Dreher, Angew. Chem. Int. Ed., 51 (2012) 1-5
...more
2011 Publications
Application of Ion Mobility Spectrometry in Drug Substance Development, H. Gao, X. Jia, R. Xiang, X. Gong, C. Welch, Analytical Methods, 3, 1828-1837, 2011.
Analytical Method Volume Intensity Index:A Green Chemistry Metric for HPLC Methodology in the Pharmaceutical Industry, R. Hartman, R. Helmy, M. Al-Sayah, C. Welch, Green Chemistry 13, 934-939, 2011.
Does an Axial Propeller Shape on a...more
2010 Publications
High-throughput metal screening in pharmaceutical samples by ICP-MS with automated flow injection using a modified HPLC configuration, Tu, Wang, Welch, J. Pharm. Biomed. Anal., 51, 90-95, 2010.
Systematic Evaluation of New Chiral Stationary Phases for Supercritical Fluid Chromatography Using a Standard Racemate Library, Pirzada, Personick, Biba, Gong, Zhou, Schafer, Welch, J. Chromaogr.A,...more
Adsorbent Screening for Metal Impurity Removal in Pharmaceutical Process(Link)
Organic Process Research & Development
February 23, 2005
A microtube screening approach affords simple and convenient assessment of the selective adsorption of metal impurities by a variety of different process adsorbents. This approach is helpful in identifying rapid solutions to metal impurity problems in pharmaceutical process research. Several examples illustrating the utility of the approach are presented.
- Online Analysis of Flowing Streams Using Microflow HPLC
Organic Process Research & Development
2009Journal of Pharmaceutical and Biomedical An
Response to Comment on “Cocktail Chromatography: Enabling the Migration of HPLC to Nonlaboratory Environments”(Link)
ACS Sustainable Chem. Eng. 2015, 3 (9), 1897.
ACS Sustainable Chem. Eng. 2015, 3 (9), 1897.
Education
FUELING INNOVATION
Welch helped launch Merck's new postdoctoral research fellowship program.
/////////Reflections on Chirality in the Pharmaceutical Industry, Past, Present and Future
Dr. Christopher J. Welch, Distinguished Scientist, Process Research & Development, Merck Research Laboratories, USA, presentation
Subscribe to:
Posts (Atom)